Protective effect of carnosine on adriamycin-induced oxidative heart damage in rats;Sıçanlarda adriamisinin neden olduǧu oksidatif kalp hasarı üzerine karnozinin koruyucu etkisi

Anadolu Kardiyoloji Dergisi

Volumn 11, Issue 1, 2011, Pages 3-10

  Özdoǧan, Kalender ^a   Taşkin, Eylem ^a   Dursun, Nurcan ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Adriamycin; Antioxidant; Cardiac damage; Carnosine; Langendorff

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARNOSINE; CATALASE; CREATINE KINASE; DOXORUBICIN; GLUTATHIONE PEROXIDASE; LACTATE DEHYDROGENASE; MALONALDEHYDE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME INACTIVATION; FEMALE; HEART HEMODYNAMICS; HEART INJURY; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART PROTECTION; HEART RATE; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; R WAVE; RAT; RR INTERVAL; ST SEGMENT ELEVATION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 79551596450     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2011.003     Document Type: Article

References (36)

1. Iqbal M, Dubey K, Anwer T, Ashish A, Pillai KK. Protective effects of telmisartan against acute doxorubicin-induced cardiotoxicity in rats. Pharmacol Rep 2008; 60: 382-90.
2. Toko H, Oka T, Zou Y, Sakamoto M, Mizukami M, Sano M, et al. Angiotensin II type 1a receptor mediates doxorubicin-induced cardiomyopathy. Hypertens Res 2002; 25: 597-603.
3. Berthiaume JM, Wallace KB. Adriamycin-induced oxidative mitochondrial cardiotoxicity. Cell Biol Toxicol 2007; 23: 15-25.
4. Chen Y, Jungsuwadee P, Vore M, Butterfield DA, St Clair DK. Collateral damage in cancer chemotherapy: oxidative stress in nontargeted tissues. Mol Interv 2007; 7: 147-56.
5. Christiansen S, Autschbach R. Doxorubicin in experimental and clinical heart failure. Eur J Cardiothorac Surg 2006; 30: 611-6.
6. Guiotto A, Calderan A, Ruzza P, Borin G. Carnosine and carnosinerelated antioxidants: a review. Curr Med Chem 2005; 12: 2293-315.
7. Assir AMA, Abdel-Wahab AFI. Carnosine protects against doxorubicine-induced cardiotoxicity. SPJ 2003; 11: 23-31.
8. Zieba R, Wagrowska-Danilewicz M. Influence of carnosine on the cardiotoxicity of doxorubicin in rabbits. Pol J Pharmacol 2003; 55: 1079-87.
9. Baykara B, Tekmen I, Pekçetin C, Ulukuş C, Tuncel P, Saǧol O, et al. The protective effects of carnosine and melatonin in ischemiareperfusion injury in the rat liver. Acta Histochem 2009; 111: 42-51.
10. Lee YT, Hsu CC, Lin MH, Liu KS, Yin MC. Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation. Eur J Pharmacol 2005; 513: 145-50.
11. Mikami K, Otaka M, Watanabe D, Goto T, Endoh A, Miura K, et al. Zinc L-carnosine protects against mucosal injury in portal hypertensive gastropathy through induction of heat shock protein 72. J Gastroenterol Hepatol 2006; 21: 1669-74.
12. Dimitrov NV, Hay MB, Siew S, Hudler DA, Charamella LJ, Ullrey DE. Abrogation of adriamycin-induced cardiotoxicity by selenium in rabbits. Am J Pathol 1987; 126: 376-83.
13. Robert J. Preclinical assessment of anthracycline cardiotoxicity in laboratory animals: predictiveness and pitfalls. Cell Biol Toxicol 2007; 23: 27-37.
14. Jain SK. Evidence for membrane lipid peroxidation during the in vivo aging of human erythrocytes. Biochim Biophys Acta 1988; 937: 205-10.
15. Stocks J, Dormandy TL. The autoxidation of human red cell lipids induced by hydrogen peroxide. Br J Haematol 1971; 20: 95-111.
16. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-69.
17. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
18. Beers RF Jr, Sizer IW. A spectrophotometric methods for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 1952; 95: 133-40.
19. Li L, Takemura G, Li Y, Miyata S, Esaki M, Okada H, et al. Preventive effect of erythropoietin on cardiac dysfunction in doxorubicininduced cardiomyopathy. Circulation 2006; 113: 535-43.
20. Roberts PR, Zaloga GP. Cardiovascular effects of carnosine. Biochemistry (Mosc) 2000; 65: 856-61.
21. Venkatesan N. Curcumin attenuation of acute adriamycin myocardial toxicity in rats. Br J Pharmacol 1998; 124: 425-7.
22. Fisher PW, Salloum F, Das A, Hyder H, Kukreja RC. Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity. Circulation 2005; 111: 1601-10.
23. le Marec H, Spinelli W, Rosen MR. The effects of doxorubicin on ventricular tachycardia. Circulation 1986; 74: 881-9.
24. Jabr RI, Cole WC. Alterations in electrical activity and membrane currents induced by intracellular oxygen-derived free radical stress in guinea pig ventricular myocytes. Circ Res 1993; 72: 1229-44.
25. Pacher P, Liaudet L, Bai P, Virag L, Mabley JG, Hasko G, et al. Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure. J Pharmacol Exp Ther 2002; 300: 862-7.
26. Saad SY, Najjar TA, Al-Rikabi AC. The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol Res 2001; 43: 211-8.
27. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med 1991; 91: 14S-22S.
28. Daosukho C, Chen Y, Noel T, Sompol P, Nithipongvanitch R, Velez JM, et al. Phenylbutyrate, a histone deacetylase inhibitor, protects against Adriamycin-induced cardiac injury. Free Radic Biol Med 2007; 42: 1818-25.
29. Mukherjee S, Banerjee SK, Maulik M, Dinda AK, Talwar KK, Maulik SK. Protection against acute adriamycin-induced cardiotoxicity by garlic: role of endogenous antioxidants and inhibition of TNF-alpha expression. BMC Pharmacol 2003; 3: 16.
30. Li T, Danelisen I, Bello-Klein A, Singal PK. Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats. Cardiovasc Res 2000; 46: 523-30.
31. Kang JH. Protective effects of carnosine and N-Acetylcarnosine on salsolinol-mediated Cu, Zn-superoxide dismutase inactivation. Bull Korean Chem Soc 2007; 28: 1881-4.
32. Hartman PE, Hartman Z, Ault KT. Scavenging of singlet molecular oxygen by imidazole compounds: high and sustained activities of carboxy terminal histidine dipeptides and exceptional activity of imidazole-4-acetic acid. Photochem Photobiol 1990; 51: 59-66.
33. Harman D. The aging process: major risk factor for disease and death. Proc Natl Acad Sci U S A 1991; 88: 5360-3.
34. Sharonov BP, Govorova NJu, Lyzlova SN. Carnosine as a potential scavenger of oxidants generated by stimulated neutrophils. Biochem Int 1990; 21: 61-8.
35. Hartman PE. Interception of toxic agents/mutagens/carcinogens: some of nature's novel strategies. Basic Life Sci 1986; 39: 169-79.
36. Kang JH, Kim KS, Choi SY, Kwon HY, Won MH, Kang TC. Protective effects of carnosine, homocarnosine and anserine against peroxyl radical-mediated Cu,Zn-superoxide dismutase modification. Biochim Biophys Acta 2002; 1570: 89-96.